Enhancing osteoblast differentiation through small molecule-incorporated engineered nanofibrous scaffold.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cell Biology

Background:

• Developing effective scaffolds is crucial for bone tissue engineering.
• Incorporating small molecules can modulate cellular responses within scaffolds.
• Lithium chloride (LiCl) is a small molecule with potential osteogenic effects.

Purpose of the Study:

• To investigate the impact of LiCl incorporated into PCL nanofiber scaffolds on osteoblast differentiation.
• To assess the effects of LiCl-modified scaffolds on cell proliferation, Wnt signaling, and mineralization.

Main Methods:

• Poly-ε-caprolactone (PCL) nanofiber matrices with LiCl were fabricated via electrospinning.
• Scaffolds were characterized using SEM and EDX.
• MC3T3-E1 cells were cultured on scaffolds and analyzed for proliferation (alamarBlue), Wnt signaling (β-catenin via Western blot), osteoblast differentiation markers (qPCR), and mineralization (Alizarin Red staining).

Main Results:

• LiCl nanofiber scaffolds promoted concentration-dependent cell proliferation and sustained Wnt signaling indicated by increased β-catenin expression.
• Expression of key osteoblast differentiation markers, including osteocalcin (OCN) and Runt-related transcription factor 2 (Runx2), was elevated.
• Increased expression of bone morphogenetic proteins (BMP-2, 4, 7) and enhanced mineral deposition were observed in LiCl-treated scaffolds.

Conclusions:

• LiCl-incorporated nanofiber scaffolds effectively enhance osteoblast differentiation and mineralization.
• These findings suggest that small molecule-modified nanofibrous scaffolds are a promising clinical tool for bone tissue engineering.